Dual-Mechanism Drop Wins FDA Approval
February 2, 2026
FDA approves Tenpoint Therapeutics’ YUVEZZI eye drop for presbyopia
1 min read
False
Advertisement
Latest
A Vision for Growth
By Jeanne Taylor Hecht , David J. Tanzer
February 2, 2026
Capital, innovation, and the next wave of ophthalmic breakthroughs
3 min read
Tackling Trachoma in Ethiopia
January 30, 2026
FLAME trial: Can a mild steroid reduce trichiasis relapse after surgery?
1 min read
Retinitis Pigmentosa’s New Genetic Player
January 29, 2026
Researchers uncover new noncoding genetic culprit in autosomal dominant retinitis pigmentosa
2 min read
Presbyopia as a Process: Why New Concepts Take Time
By Miriam Meddour
January 29, 2026
Presbyopia evolves over time; our treatment thinking should tooÂ
4 min read
The Ophthalmologist’s Time Machine: Chapter 36
By Stephen G. Schwartz, Charles E. Letocha, Christopher T. Leffler, ..et al.
January 28, 2026
The Spectacular Invention of Spectacles
3 min read
Blink and You’re Powered
January 28, 2026
Could an innovative new blink-powered design signal a self-sustaining future for eye tracking devices?
2 min read
Leapfrogging from Discomfort to the Joy of Sales
By Rod Solar
January 27, 2026
Why sales is a skill eye surgeons must master
7 min read
When Ointment Meets Implant
January 27, 2026
Petrolatum-based ointments induce swelling in exposed PERSERFLOÂ MicroShunts
2 min read
Myopia: Evidence That Endures
By Natalia Vlasak
January 26, 2026
Why robust long-term clinical myopia control evidence is crucial for protecting children’s vision
3 min read
Browse by Subspecialties
False
Advertisement